Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage
…, C González-Navas, J Calvo-Gutiérrez… - Clinical …, 2018 - Springer
To evaluate quality of life (QoL) in patients with axial spondyloarthritis (axSpA) and its association
with disease activity, functionality, structural damage, and spinal mobility, using patient-…
with disease activity, functionality, structural damage, and spinal mobility, using patient-…
[HTML][HTML] Safety and effectiveness of abatacept in a prospective cohort of patients with rheumatoid arthritis–associated interstitial lung disease
…, M Gandía-Martínez, J Calvo-Gutiérrez… - Biomedicines, 2022 - mdpi.com
Objective: To prospectively evaluate the safety and efficacy profile of abatacept in patients
with rheumatoid arthritis–associated interstitial lung disease (RA-ILD). Methods: We …
with rheumatoid arthritis–associated interstitial lung disease (RA-ILD). Methods: We …
Óptima utilización del metotrexato
RO Castro, AE Contreras, JC Gutiérrez… - Seminarios de la …, 2013 - Elsevier
El metotrexato es considerado hoy en día como el fármaco antirreumático modificador de la
enfermedad de primera elección en el tratamiento de la artritis reumatoide, en razón a su …
enfermedad de primera elección en el tratamiento de la artritis reumatoide, en razón a su …
Cardiovascular risk factors in patients with spondyloarthritis from Northern European and Mediterranean countries: an ancillary study of the ASAS-COMOSPA project
…, S Ozgocmen, M Dougados, J Calvo-Gutiérrez… - Joint Bone Spine, 2018 - Elsevier
Objectives The objectives of this study were: (1) to compare the prevalence of cardiovascular
disease and cardiovascular risk factors among different phenotypes of spondyloarthritis (…
disease and cardiovascular risk factors among different phenotypes of spondyloarthritis (…
[HTML][HTML] Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study
…, A Garcia-Studer, J Calvo-Gutiérrez… - Biomedicine & …, 2023 - Elsevier
Objectives To describe comorbid conditions in patients with rheumatoid arthritis–associated
interstitial lung disease (RA-ILD) and to analyze factors associated with multimorbidity. …
interstitial lung disease (RA-ILD) and to analyze factors associated with multimorbidity. …
Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis
…, J Calvo-Gutiérrez… - … in Chronic Disease, 2020 - journals.sagepub.com
Objective: To analyze the relationship between complement component 3 (C3) and the
prevalence of cardiometabolic risk factors and disease activity in the rheumatic diseases having …
prevalence of cardiometabolic risk factors and disease activity in the rheumatic diseases having …
Is spinal mobility in patients with spondylitis determined by age, structural damage, and inflammation?
J Calvo‐Gutierrez, JL Garrido‐Castro… - Arthritis Care & …, 2015 - Wiley Online Library
… 1Jerusalem Calvo-Gutierrez, MD: Universitario Reina Sofia, and Maimonides Institute for …
Calvo-Gutierrez had full access to all of the data in the study and takes responsibility for the …
Calvo-Gutierrez had full access to all of the data in the study and takes responsibility for the …
Assessment of fatigue in spondyloarthritis and its association with disease activity
…, MC Castro-Villegas, J Calvo-Gutiérrez… - The Journal of …, 2016 - jrheum.org
Objective. To evaluate fatigue in patients with spondyloarthritis (SpA) and to define its
association with disease-related factors and patients’ features. Methods. A cross-sectional …
association with disease-related factors and patients’ features. Methods. A cross-sectional …
[HTML][HTML] Molecular characterization of monocyte subsets reveals specific and distinctive molecular signatures associated with cardiovascular disease in rheumatoid …
…, Y Jimenez-Gomez, J Calvo-Gutierrez… - Frontiers in …, 2019 - frontiersin.org
Objectives: This study, developed within the Innovative Medicines Initiative Joint Undertaking
project PRECISESADS framework, aimed at functionally characterize the monocyte …
project PRECISESADS framework, aimed at functionally characterize the monocyte …
[HTML][HTML] Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
…, B Garcia-Magallon, J Calvo-Gutiérrez… - Scientific Reports, 2021 - nature.com
The better understanding of the safety of biologic DMARDs (bDMARDs), as well as the
emergence of new bDMARDs against different therapeutic targets and biosimilars have likely …
emergence of new bDMARDs against different therapeutic targets and biosimilars have likely …